Contents
Academic literature on the topic 'Cystorelin'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cystorelin.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Cystorelin"
1
Holz, J. P., P. L. Houghton, and M. F. Spire. "Use of Cystorelin® and artificial insemination in repeat-breeding beef heifers after estrous synchronization." Kansas Agricultural Experiment Station Research Reports, no. 1 (January 1, 1993): 86–87. http://dx.doi.org/10.4148/2378-5977.2089.
Full text
2
Small, J., F. Dias, L. Pfeifer, K. Lightfoot, M. Colazo, J. Kastelic, and R. Mapletoft. "20 ADMINISTRATION OF FOLLICLE-STIMULATING HORMONE AT CIDR REMOVAL DOES NOT AFFECT THE PREGNANCY RATE IN A CIDR-BASED, COSYNCH PROTOCOL IN LACTATING BEEF COWS." Reproduction, Fertility and Development 20, no. 1 (2008): 90. http://dx.doi.org/10.1071/rdv20n1ab20.
Full textAbstract:
In previous studies, giving eCG at CIDR removal significantly increased the pregnancy rate after timed-AI in beef cows. However, eCG is not universally available. Therefore, we tested the hypothesis that giving pFSH at CIDR removal might improve the pregnancy rate in a CIDR-based, Cosynch protocol in postpartum, suckled Bos taurus beef cows; a secondary objective was to compare pregnancy rates when GnRH v. pLH was used to synchronize wave emergence and ovulation. This work was conducted as two experiments (separate locations). All cows were given a CIDR (containing 1.9 g progesterone; Pfizer Animal Health, Montreal, QC, Canada) on Day 0 (without regard to stage of estrous cycle or cyclicity). On Day 7, CIDRs were removed, all cows were concurrently given 25 mg PGF (Lutalyse; Pfizer Animal Health, Groton, CT, USA), half were given 20 mg pFSH (Folltropin-V; Bioniche Animal Health, Belleville, ON, Canada), and all cows were timed-AI 54 h later (Day 9). In Experiment 1, 240 cows [94 � 10.8 days postpartum; body condition score (BCS: 1 = emaciated, 9 = obese; mean � SD): 5.8 � 0.4] were used; at CIDR insertion and AI, cows were allocated to receive either 100 µg GnRH (n = 160; Cystorelin, Merial Canada Inc., Victoriaville, QC, Canada) or 12.5 mg pLH (n = 80; Lutropin-V, Bioniche Animal Health). In Experiment 2, 109 cows (59.2 � 19.5 days postpartum; BCS: 5.6 � 1.1) were used; all received 100 µg GnRH (Cystorelin) at CIDR insertion and AI. In Experiment 1, three cows that lost their CIDR were excluded; pregnancy rates after timed-AI (logistic regression, backward selection: parity, pFSH, synchronizing treatment, and their interactions) were not different between cows given pFSH v. control cows (64.7 v. 65.2%; P > 0.80), nor between cows given GnRH v. pLH (62.7 v. 69.6%; P = 0.91). However, there was an interaction (P < 0.04) between parity and the synchronizing treatment; in primiparous cows, pregnancy rates were significantly lower in those given GnRH v. pLH (59.3 v. 83.3%). In Experiment 2, pregnancy rates after timed-AI (logistic regression, backward selection: parity, pFSH, and their interaction) were not different between cows given pFSH v. control cows (38.2 v. 42.6%; P > 0.6). In conclusion, our hypothesis was not supported; giving pFSH at CIDR removal did not significantly improve the pregnancy rate in a CIDR-based, Cosynch protocol in postpartum, suckled Bos taurus beef cows.
3
Kohram, H., V. Vahedi, S. Nasrollahi, and A. Farahavar. "Superovulation following follicular synchronization with GnRH at random stages of the oestrous cycle in heifers." Czech Journal of Animal Science 56, No. 1 (January 20, 2011): 7–14. http://dx.doi.org/10.17221/325/2009-cjas.
Full textAbstract:
The objective of this study was to develop a superovulatory program based on synchronization of follicular waves with GnRH which could be applied regardless of the stage of the oestrous cycle. 36 heifers were subjected to this experiment and GnRH (Cystorelin, 200 µg) was applied between Days 0 and 7 (n = 15), 8 and 12 (n = 8) or 13 and 20 (n = 13) of the oestrous cycle. Four days after GnRH treatment, all follicles ≥ 6 mm of heifers (n) were either punctured (n = 21) or left intact (n = 15). All heifers were superstimulated from Day 6 to Day 10 after GnRH treatment with 320 mg Folltropin-V. In parallel, 21 heifers were superstimulated in a conventional manner (Days 8 to 12) and were used as controls. The homogeneity of follicular inventories among Stage-groups occurred within 4 days of GnRH treatment for follicles ≥ 7 mm but only 2 days after follicular puncture for follicles 4 to 6 mm. In response to the follicular puncture, the mean number of follicles 4 to 6 mm increased in heifers of the punctured group (P < 0.01). Following the superstimulation, the follicular (P < 0.01) and ovulatory (P < 0.01) responses were higher in the punctured group than in the nonpunctured group. The in vivo production of transferable embryos in the punctured group was similar to that of the nonpunctured group but it was lower (P < 0.01) than in heifers of the control group. In conclusion, results from the present study indicate that regardless of the stage of the oestrous cycle, the homogeneity of follicular inventories following the follicular synchronization is obtained using GnRH treatment and follicular puncture. The in vivo production of embryos was severely compromised in the present study with heifers. Causes of such reduction in the in vivo production of embryos are still unknown.
4
Bogle, O. A., M. H. Ratto, and G. P. Adams. "221 PREPUBERTAL MOUSE BIOASSAY FOR OVULATION-INDUCING FACTOR IN SEMINAL PLASMA." Reproduction, Fertility and Development 20, no. 1 (2008): 190. http://dx.doi.org/10.1071/rdv20n1ab221.
Full textAbstract:
A substance in the seminal plasma of llamas and alpacas has been discovered that induces ovulation and growth of the corpus luteum (CL) in the female of the same species. The ovarian effects of the ovulation-inducing factor (OIF) are associated with a surge release of LH into circulation. Ultrasonographic detection of ovulation and CL development is currently the only method available for testing the bioactive effects of OIF. The purpose of this study was to determine if a superstimulatory prepubertal mouse model could be developed as an in vivo bioassay for OIF. Prepubertal female CD1 mice (n = 144), 20 days of age and weighing 20–25 g, were housed at 24�C with lights on from 0500 to 1900 h and free access to food and water. An intramuscular dose of 5 IU of eCG (Novormon, Bioniche Animal Health, Belleville, ON, Canada) was given (Day 0) for ovarian superstimulation. On Day 2, mice were assigned randomly to 4 groups (n = 36 per group) and given a single 0.1 mL intraperitoneal dose of (1) 5 IU of hCG (Chorulon, Intervet Canada, Ltd., Whitby, ON, Canada), (2) 5 µg GnRH (gonadotropin-releasing hormone: Cystorelin, Merial, Ltd., Iselin, NJ, USA), (3) llama seminal plasma, or (4) phosphate-buffered saline (negative control). On Day 3, females were euthanized by an overdose of inhaled halothane. Oviducts were collected and oocytes were counted using trans-illumination stereomicroscopy. The proportion of mice that ovulated did not differ among groups treated with hCG, GnRH, and seminal plasma (31/36, 31/36, 28/36, respectively); however, the proportion of mice that ovulated in each treatment group was greater than that in the saline-treated group (9/36) (P < 0.001). The number of oocytes counted (mean � SEM) was also similar among groups treated with hCG (25.8 � 2.9), GnRH (27.4 � 2.7), and seminal plasma (19.2 � 2.8), all of which were greater (P < 0.01) than in the saline-treated group (6.2 � 2.1). We conclude that the superstimulated prepubertal CD1 mouse model is effective as an in vivo bioassay for OIF in seminal plasma. Whether the bioassay may be used for quantitative estimates of OIF activity will require dose-response trials using serial dilutions of seminal plasma.
5
Wock, J. M., L. M. Lyle, and M. E. Hockett. "297 EFFECT OF GONADOTROPIN-RELEASING HORMONE COMPARED WITH ESTRADIOL-17β AT THE BEGINNING OF A SUPERSTIMULATION PROTOCOL ON SUPEROVULATORY RESPONSE AND EMBRYO QUALITY." Reproduction, Fertility and Development 20, no. 1 (2008): 228. http://dx.doi.org/10.1071/rdv20n1ab297.
Full textAbstract:
Success of a superstimulation protocol is largely dependent on avoiding the effects of the dominant follicle. The objective of this study was to determine if gonadotropin-releasing hormone (GnRH) would serve as a suitable alternative to the traditional estradiol-17β in a superstimulation protocol when using a CIDR. Dairy cattle (n = 411) were superstimulated using one of two treatment protocols. The GnRH-treated animals received a CIDR on random days of the estrous cycle (day 0), and GnRH was injected i.m. (100 micrograms of Cystorelin) on day 3. Porcine FSH (Folltropin-V) was administered twice daily in decreasing doses on days 5 to 8, and on day 8, CIDR were removed and 25 mg of dinoprost (PGF2α) was administered twice. The Estradiol-treated animals received a CIDR and 4 mg estradiol-17β i.m. on random days of the estrous cycle (day 0). Porcine FSH was administered twice daily in decreasing doses on days 4 to 7, and on day 7, CIDR were removed and 25 mg of PGF2α was administered twice. All animals were artificially inseminated at standing estrus and at 6-h intervals during estrus. Animals were inseminated a minimum of twice, and those with extended estrous periods were inseminated three times. Animals not showing estrus were inseminated once 48 h after CIDR removal. Seven days following estrus, embryos were collected. For data analysis, animals were divided into lactating cows, dry cows, and heifers. Dosage of FSH for each animal varied according to previous response rates; therefore, animals were further subclassified as high FSH (≥300 mg in 15 mL) or low FSH (<300 mg in 15 mL). As there were no heifers on high FSH, data analysis was done as a 5 � 2 factorial ANOVA. Total number of ova/embryos, quality, development, and fertilization rates were recorded. Analysis of data showed no statistical differences (P > 0.05) between Estradiol- and GnRH-treated groups for number ova/embryos recovered (9.8 � 0.58 v. 9.7 � 0.65), IETS-grade 1 and 2 embryos (4.7 � 0.37 v. 4.5 � 0.41), percentage fertilized (54.1 � 2.5 v. 53.2 � 2.9), and percentage grade 1 and 2 embryos (49.2 � 2.5 v. 49.3 � 2.8), respectively. No significant interactions were found between treatment and lactation status or treatment and FSH dose. Data suggest that GnRH in combination with a CiDR is an effective means of synchronizing follicle wave emergence in a superstimulation protocol. George Seidel, Josh Walker, John Hassler, and Sam Galphin.
6
Dupras, R., and Y. Chorfi. "139 NEW APPROACH FOR BOVINE EMBRYO RECOVERY." Reproduction, Fertility and Development 21, no. 1 (2009): 169. http://dx.doi.org/10.1071/rdv21n1ab139.
Full textAbstract:
The objective of this study was to evaluate the use of a second flush for bovine embryo recovery. A total of 319 clinically healthy Holstein cows (247 lactating, 53 dry, 19 nulliparous) with an average age of 5.5 ± 2.5 years were used for this experiment. Superovulation was performed according to a modified method of Baracaldo et al. (2000). On Day 0 (beginning of the experiment), each cow received 3 mg of estradiol-17β intramuscularly (i.m.) and a progesterone-releasing vaginal insert (1.9 g of progesterone, CIDR, Pfizer Animal Health, Kirkland, QC, Canada) at random stages of the estrous cycle. From Day 4 evening to Day 8 evening, the cows received a total of 380 mg of NIH-FSH-P1 (FolltropinV, Bioniche Animal Health) administered im through 9 injections of decreasing dose (from 70 to 20 mg) at 12-h intervals. On Day 7, the cows received 2 injections consisting of 500 μg of cloprostenol (prostaglandin F2α analogue Estrumate, Schering-Plough, Pointe-Claire, QC, Canada) given approximately 12 h apart and vaginal inserts were removed 12 h after the last injection. Artificial insemination was performed on Day 10 after treatment with 100 μg, GnRH im (Cystorelin, Merial Canada Inc, Baie d’Urfe, QC, Canada). Embryos were flushed from the uterus of donor cows 6 days after AI. The method consisted of using simultaneously 1 catheter (18Fr Silicone 2-way, Bioniche Animal Health) per uterine horn. Catheters were maintained in place to perform 2 flushes 1 h apart. A total of 1000 mL of flushing media (Complete flush, Bioniche Animal Health) were used, 700 mL and 300 mL for the first and the second flush, respectively. Embryos were assessed for viability immediately after collection using IETS classification. Data were analyzed using the SAS MIXED procedure (SAS Institue, Cary, NC). The mean (±SD) number of embryos collected at the first flushing was 5.87 ± 5.1, 0.92 ± 2.2 and 2.9 ± 4.4 for transferable, degenerate and unfertilized oocytes, respectively. The second flushing yielded 2.32 ± 2.6 transferable embryos, 0.28 ± 0.83 dead embryos and 1.2 ± 2.2 unfertilized oocytes. There was no significant effect of age, day in milk, or stage of lactation on transferable or degenerate embryos or nonfertilized oocytes in each flushing. The embryo recovery method used in this experiment could be used to recover more transferable embryos. The authors want to thank Dr Vincent Girard for his help in statistics.
7
Dupras, R., J. Dupras, and Y. Chorfi. "173 ESTRADIOL-17β CONCENTRATIONS IN BLOOD AND MILK DURING SUPEROVULATORY TREATMENT IN DAIRY COWS." Reproduction, Fertility and Development 22, no. 1 (2010): 245. http://dx.doi.org/10.1071/rdv22n1ab173.
Full textAbstract:
In cows, estradiol-17β is usually used to synchronize follicular wave emergence during superovulatory treatment. This approach, however, raises some concerns about the presence of estrogens in bovine products and their possible association with some human estrogen-sensitive cancers. The objective of this study was to determine estradiol-17β concentrations in blood and milk of dairy cows after i.m. injection of estradiol-17β and to compare these concentrations to those obtained during standard superovulation protocols. Six cows were used for this experiment. On Day 0, corresponding to Day 7 of their ensuing cycle, cows received 4.5 mg of estradiol-17β (Gentes et Bolduc, St-Hyacinthe, Québec, Canada) via i.m. injection and a progesterone-releasing vaginal insert (1.9 g of progesterone, CIDR, Pfizer Animal Health, Kirkland, Québec, Canada). Blood and milk samples were taken at 0, 24, 48, and 72 h after injection. From Day 4 evening to Day 8 evening, the cows received a total of 380 mg of NIH-FSH-P1 (Folltropin-V, Bioniche Animal Health, Belleville, Ontario, Canada) administered i.m. through 9 injections of decreasing dose (from 70 to 20 mg) at 12-h intervals. On Day 7, the cows received 2 injections consisting of 500 μg of cloprostenol (prostaglandin F2 α analogue, Estrumate, Shering-Plough, Pointe-Claire, Québec, Canada) given approximately 12 h apart and vaginal inserts were removed 12 h after the last injection. Artificial insemination was performed on Day 9 and 10 after treatment with 100 μg of GnRH i.m. (Cystorelin, Merial Canada Inc., Baie Urfe, Québec, Canada). A second batch of blood and milk samples was taken at Day 8, 9, 10, and 11. Measurement of estradiol-17β was performed with an IMMULITE chemiluminescent counter using an IMMULITE Estradiol Kit (Siemens Diagnostic Products Corporation, Los Angeles, CA, USA). Concentrations of estradiol-17β in blood (37.1 ± 15.6 pg mL-1 at 24 h, 19.1 ± 14.2 pg mL-1 at 48 h) and milk (38.4 ± 29.5 pg mL-1 at 24 h, 9.3 ± 4.9 pg mL-1 at 48 h) were significantly higher after i.m. injection of 4.5 mg of estradiol-17β. In comparison, superovulation heat (Day 9 to 11) increased estradiol-17β concentrations in blood (20 ± 13.6 pg mL-1 at 24 h, 32.5 ± 16.3 pg mL-1 at 48 h) but not in milk.
8
Bartolome, J. A., A. Sozzi, J. McHale, K. Swift, D. Kelbert, L. F. Archbald, and W. W. Thatcher. "8RESYNCHRONIZATION OF OVULATION AND TIMED INSEMINATION IN LACTATING DAIRY COWS USING THE OVSYNCH AND HEATSYNCH PROTOCOLS INITIATED 7 DAYS BEFORE PREGNANCY DIAGNOSIS ON DAY 30 BY ULTRASONOGRAPHY." Reproduction, Fertility and Development 16, no. 2 (2004): 126. http://dx.doi.org/10.1071/rdv16n1ab8.
Full textAbstract:
Rapid re-synchronization of ovulation and insemination in cows found nonpregnant to a previous service is important to maintain high reproductive efficiency. The objective was to compare pregnancy rate (PR) and pregnancy losses (PL) in cows subjected to Ovsynch or Heatsynch protocols 7 days before pregnancy diagnosis by ultrasonography (U/S) on Day 30. Initiation of both protocols included administration of GnRH on Day 23, which was considered the optimal time according to the distribution of interestrus intervals in cows previously inseminated. The study was conducted in a large dairy herd located in north central Florida from March to May, 2003. Of 593 cows treated with GnRH on Day 23 (±1) after insemination and found nonpregnant at U/S on Day 30 (±1; experimental Day 0), 75% (445) had a CL (diestrus) and were sequentially assigned to the two experimental groups. Cows in the Ovsynch Group (n=225) received 25mg (i.m.) PGF2α (Lutalyse, Pharmacia, Kalamazoo, MI, USA) on Day 0, 100μg (i.m.) GnRH (Cystorelin, Merial Limited, Iselin, NJ, USA) on Day 2, and were timed inseminated 16h later. Cows in Heatsynch Group (n=220) received 25mg (i.m.) PGF2α on Day 0, and 1mg (i.m.) estradiol cypionate (ECP, Pharmacia, Kalamazoo, MI, USA) on Day 1, and were timed-inseminated 36h later. Pregnancy at Day 30 was determined by U/S and at Day 55 by rectal examination of the genital tract. Pregnancy rate and PL were evaluated using multiple logistic regression. Pregnancy rate at Day 30 for Ovsynch (64/225, 28.4%) and Heatsynch (63/220, 28.6%) and PR at Day 55 for Ovsynch (58/225, 25.8%) and Heatsynch (54/220, 24.5%) were not different. In addition, PL between Days 30 and 55 for Ovsynch (6/64, 9.4%) and Heatsynch (9/63, 14.3%) were not different. There were no effects of parity, inseminator and days in milk on PR. However, PR at day 30 was higher in lots with cooling systems (46/141, 32.6%) and lots of first calf heifers (41/135, 30.4%) compared to lots of multiparous cows late in lactation without cooling systems (32/148, 21.6%). In conclusion, Heatsynch and Ovsynch initiated 7 days before pregnancy diagnosis on Day 30 had comparable PR of 25% at Day 55 in lactating dairy cows during the period of March–May.
9
Campos, Carla Cristian, Mayara Oliveira, Renata De Freitas Ferreira Mohallem, and Ricarda Maria dos Santos. "Gonadorelina no início e/ou no final do protocolo de sincronização da ovulação a base de progesterona e benzoato de estradiol em fêmeas Nelore." Semina: Ciências Agrárias 37, no. 1 (February 29, 2016): 173. http://dx.doi.org/10.5433/1679-0359.2016v37n1p173.
Full textAbstract:
<p>Objetivou-se avaliar os efeitos da gonadorelina (GnRH) utilizada para sincronização da emergência da onda de crescimento folicular e para indução da ovulação sincronizada ou em ambos sobre a taxa de concepção (TC) de vacas da raça Nelore. O experimento foi realizado em duas fazendas no Vale do Araguaia, MT. A avaliação do escore de condição corporal (ECC) e a ultrassonografia para determinação da condição dos ovários [folículo com diâmetro < 10 mm, ? 10 mm ou presença de corpo lúteo (CL)] foram realizadas no início (Dia 0) do protocolo de inseminação artificial em tempo fixo (IATF). Vacas multíparas (n = 494) foram submetidas ao protocolo: Dia 0 – inserção do dispositivo intravaginal de progesterona (P4, DIB®, MSD) utilizado previamente por oito ou 16 dias e aplicação IM de 2,0 mg de Benzoato de Estradiol (BE, Gonadiol®, MSD); Dia 8 – remoção do dispositivo, aplicação IM de 300 UI de Gonadotrofina Coriônica Equina (eCG, Folligon®, MSD), de 1,0 mg de Cipionato de Estradiol (ECP®, Zoetis) e de 0,265 mg de Cloprostenol Sódico (PGF2?, Ciosin®, MSD); Dia 10 – IATF, realizada por um único inseminador. Os animais foram distribuídos aleatoriamente em quatro grupos: controle (n = 126), GnRH D0 (n = 123), GnRH D10 (n = 123) e GnRH D0 + D10 (n = 122), sendo que os animais tratados com GnRH receberam 50 mcg de gonadorelina (GnRH, Cystorelin®, Merial). O diagnóstico de gestação foi realizado por ultrassonografia 39 ± 10 dias após a IATF. As variáveis foram analisadas pelo procedimento GLIMMIX do programa SAS (P < 0,05). Verificou-se uma TC geral de 42,71%. Não foi detectado efeito dos tratamentos sobre a TC (P = 0,2482), que foi de 36,89% ± 0,19 (47/126) para o grupo controle, 46,08% ± 0,19 (56/123) para GnRH D0, 48,30% ± 0,18 (61/123) para GnRH D10 e de 38,48% ± 0,19 (47/122) para GnRH D0 + D10. Observou-se efeito da variável fazenda, sendo que na Fazenda A a TC foi de 47,32% ± 0,13 e na Fazenda B de 38,24% ± 0,13 (P = 0,0249). Não foi verificado efeito das interações entre fazenda e tratamento (P = 0,7662), nem entre condição ovariana e tratamento (P = 0,1225) sobre a TC. Vacas com folículos < 10 mm apresentaram menor TC (16,44% ± 0,08; P = 0,0001), quando comparadas às vacas com folículos ? 10 mm (46,15% ± 0,07) e vacas com CL (48,35% ± 0,07). Conclui-se que a utilização de gonadorelina para sincronização da emergência da onda de crescimento folicular e/ou como indutor da ovulação nos protocolos de IATF não promove incremento na taxa de concepção de vacas da raça Nelore.</p>
10
Messerschmidt, C. A., F. M. Abreu, L. H. Cruppe, M. V. Biehl, M. L. Day, C. R. F. Pinto, and M. A. Coutinho da Silva. "9 EFFECTS OF MECLOFENAMIC ACID ON LUTEAL FUNCTION OF BEEF CATTLE." Reproduction, Fertility and Development 24, no. 1 (2012): 115. http://dx.doi.org/10.1071/rdv24n1ab9.
Full textAbstract:
The objective of this study was to determine the effects of meclofenamic acid, a nonsteroidal anti-inflammatory, on luteal function of beef cattle. A total of 18 Angus cows, aged between 2 and 3 years old, were enrolled in the experiment. All cows were synchronized using a 5-day CIDR protocol. Briefly, cows received 100 μg of gonadorelin diacetate tetrahydrate (GnRH; Cystorelin®, Merial, Athens, GA, USA) and a controlled internal drug release insert (CIDR; Eazi-BreedTM CIDR®, Pfizer Animal Health, New York, NY, USA). Five days later, the CIDR was removed and 50 mg of dinoprost (Lutalyse®, Pfizer Animal Health) was administered intramuscularly. Oestrus was determined by twice daily observations of mounting behaviour and tail painting scores (day of oestrus = Day 0). At 72 h after dinoprost, a second dose of gonadorelin (100 μg, IM) was administered. On Day 14, cows were randomly assigned to the following treatment groups: 1) control: 10 mL of saline solution administered IM; 2) systemic: 2 g of meclofenamic acid administered IM; and 3) oral: 2 g of meclofenamic acid administered orally. Cows were treated once daily for 11 days (i.e. until Day 24) and no adverse reactions were observed. Blood sampling and ovarian ultrasonography were performed every 72 h from Day 0 until Day 12 and then every 48 h until the end of the study. Serum progesterone concentrations were determined by radioimmunoassay and were used to determine functional luteolysis (i.e. progesterone <1 ng mL–1). Ovaries were evaluated for the presence of a corpus luteum and to evaluate follicular growth and subsequent ovulation. One-way ANOVA was used to compare the day of peak progesterone concentration, lifespan of the corpus luteum and the length of the oestrous cycle between groups. Significance was set at P < 0.05 and data are presented as means ± standard error of the mean (Table 1). There were no effects of meclofenamic acid administration on any of the parameters evaluated (P > 0.05). In conclusion, meclofenamic acid administration did not affect luteal function in our study. Potentially, higher doses of meclofenamic acid may be necessary to inhibit prostaglandin synthesis and prevent luteolysis. Table 1.Effects of meclofenamic acid administration on the day of peak progesterone concentration, lifespan of the corpus luteum (CL) and the length of oestrous cycle in beef cows (mean ± standard error of the mean) Funding was provided by The Ohio State University, College of Veterinary Medicine, USDA-Animal Health Formula Funds. The authors are also grateful to the staff at the OSU Beef Center Facility for helping with animal handling and care.
Dissertations / Theses on the topic "Cystorelin"
1
Cline, Mark Andrew. "Efficacy of Synthetic Gonadotropin Releasing Hormone Analogs for Control of Ovulation During Estrus Synchronization Protocols." Thesis, Virginia Tech, 2002. http://hdl.handle.net/10919/31372.
Full textAbstract:
Two experiments were conducted to determine efficacy of GnRH analogs, Cystorelin (CYS, gonadorelin diacetate tytrahydrate) and Factrel (FAC, gonadorelin hydrochloride), for use in beef timed AI synchronization. In Experiment one 342 beef cows from 7 herds were assigned CYS or FAC treatment as part of the Ovsynch protocol (GnRH d 0 and 9, Lutalyse d 7). Cattle treated with FAC had greater tendency (P=.09) to be pregnant at d 45. One individual herd demonstrated FAC-treated cows had more pregnancies at day 45. In Experiment two, 18 beef cows received either CYS or FAC as part of the Ovsynch protocol, intensive blood samples, from time -30 to 525 min post GnRH, were collected at each GnRH injection. Ultrasounds were conducted daily over the course of the protocol. A treatment by phase interaction (P=.03) was found for the time to maximum LH concentration, where CYS-treated follicular cows had a shorter interval than did FAC treated follicular or luteal cows. The duration of detectable LH response showed a treatment by phase interaction (P = .02) where follicular and luteal CYS-treated cows had shorter interval than follicular or luteal FAC-treated cows. The variables maximum LH concentration, and area under LH curve did not differ. Cows treated with CYS had more (P=.02) non-dominant follicles. In Experiment three, 16 ewes randomly received either CYS, FAT or Fertagyl (FER; gonadorelin diacetaate tytrahydrate), and FAT's induced LH maximum concentration occurred sooner (P=.02) than CYS. We conclude that either product may be used in beef cows without compromising fertility.Master of Science